{"DataElement":{"publicId":"5777238","version":"1","preferredName":"Patient International Neuroblastoma Risk Group Classification System Stage","preferredDefinition":"Information regarding patient with neuroblastoma disease in classification system developed to establish a consensus approach for pretreatment risk stratification of neuroblastomas.","longName":"Pt_INRG_Class_Sys_Stg","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"5774026","version":"1","preferredName":"Patient International Neuroblastoma Risk Group Classification System Stage","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._A classification system developed to establish a consensus approach for pretreatment risk stratification of neuroblastomas._Any distinct time period in a sequence of events.","longName":"2233604v1.0:5774024v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6607599","version":"1","preferredName":"International Neuroblastoma Risk Group Classification System Stage","preferredDefinition":"A classification system developed to establish a consensus approach for pretreatment risk stratification of neuroblastomas.:Any distinct time period in a sequence of events.","longName":"C102563:C48308","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Neuroblastoma Risk Group Classification System","conceptCode":"C102563","definition":"A classification system developed to establish a consensus approach for pretreatment risk stratification of neuroblastomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage","conceptCode":"C48308","definition":"Any distinct time period in a sequence of events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EF7CE30-D9EE-5C79-E053-F662850A797C","latestVersionIndicator":"Yes","beginDate":"2019-01-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-01-08","modifiedBy":"ONEDATA","dateModified":"2019-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D138C4E-E253-38FF-E053-F662850AA207","latestVersionIndicator":"Yes","beginDate":"2017-04-13","endDate":null,"createdBy":"CHANGP","dateCreated":"2017-04-13","modifiedBy":"MAESKEB","dateModified":"2019-01-08","changeDescription":"ANBL1531-PDC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5777232","version":"1","preferredName":"International Neuroblastoma Risk Group Classification System Stage","preferredDefinition":"A classification system developed to establish a consensus approach for pretreatment risk stratification of neuroblastomas._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"5777232v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Ms","valueDescription":"INRG Stage MS","ValueMeaning":{"publicId":"5777234","version":"1","preferredName":"INRG Stage MS","longName":"5777234","preferredDefinition":"INRG stage L1 or L2 neuroblastoma with metastatic disease confined to the skin and/or liver and/or bone marrow.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"INRG Stage MS","conceptCode":"C133431","definition":"INRG stage L1 or L2 neuroblastoma with metastatic disease confined to the skin and/or liver and/or bone marrow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D754865-697F-4A91-E053-F662850AECC0","latestVersionIndicator":"Yes","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D754865-699B-4A91-E053-F662850AECC0","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"ONEDATA","dateModified":"2017-04-18","deletedIndicator":"No"},{"value":"M","valueDescription":"INRG Stage M","ValueMeaning":{"publicId":"5777235","version":"1","preferredName":"INRG Stage M","longName":"5777235","preferredDefinition":"Neuroblastoma with distant metastatic disease (except MS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"INRG Stage M","conceptCode":"C133430","definition":"Neuroblastoma with distant metastatic disease (except MS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D754865-69A7-4A91-E053-F662850AECC0","latestVersionIndicator":"Yes","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D754865-69C2-4A91-E053-F662850AECC0","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"ONEDATA","dateModified":"2017-04-18","deletedIndicator":"No"},{"value":"L2","valueDescription":"INRG Stage L2","ValueMeaning":{"publicId":"5777236","version":"1","preferredName":"INRG Stage L2","longName":"5777236","preferredDefinition":"Locoregional neuroblastoma with one or more image defined risk factors (IDRFs).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"INRG Stage L2","conceptCode":"C133429","definition":"Locoregional neuroblastoma with one or more image defined risk factors (IDRFs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D754865-69CE-4A91-E053-F662850AECC0","latestVersionIndicator":"Yes","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D754865-69E9-4A91-E053-F662850AECC0","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"ONEDATA","dateModified":"2017-04-18","deletedIndicator":"No"},{"value":"L1","valueDescription":"INRG Stage L1","ValueMeaning":{"publicId":"5777237","version":"1","preferredName":"INRG Stage L1","longName":"5777237","preferredDefinition":"Locoregional neuroblastoma without image defined risk factors (IDRFs).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"INRG Stage L1","conceptCode":"C133428","definition":"Locoregional neuroblastoma without image defined risk factors (IDRFs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D754865-69F5-4A91-E053-F662850AECC0","latestVersionIndicator":"Yes","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D754865-6A10-4A91-E053-F662850AECC0","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"ONEDATA","dateModified":"2017-04-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6010105","version":"1","preferredName":"International Neuroblastoma Risk Group Classification System Stage","preferredDefinition":"A classification system developed to establish a consensus approach for pretreatment risk stratification of neuroblastomas.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C102563:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Neuroblastoma Risk Group Classification System","conceptCode":"C102563","definition":"A classification system developed to establish a consensus approach for pretreatment risk stratification of neuroblastomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C3B0F64-75B1-0543-E053-F662850AF356","latestVersionIndicator":"Yes","beginDate":"2017-10-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-24","modifiedBy":"ONEDATA","dateModified":"2017-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D754865-6968-4A91-E053-F662850AECC0","latestVersionIndicator":"Yes","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"COOPERM","dateModified":"2017-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"5806867","version":"1","longName":"Neuroblastoma","context":"OCG"}]}],"AlternateNames":[{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"patient_INRG_system_stage","type":"HCMI Name","context":"OCG"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"What is patient's INRG stage?","type":"Preferred Question Text","description":"What is patient's INRG stage?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"INRG Stage:","url":null,"context":"COG"},{"name":"HCMI Question Text","type":"Alternate Question Text","description":"International Neuroblastoma Risk Group Classification System Stage","url":null,"context":"OCG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"INRG stage at the time of first designation of high risk disease:","url":null,"context":"COG"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"What was patient's INRG stage at the time of high risk diagnosis?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D755B69-3C23-4D35-E053-F662850A2D27","latestVersionIndicator":"Yes","beginDate":"2017-04-18","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-18","modifiedBy":"STARGELM","dateModified":"2020-09-02","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}